Mutations in the bak Gene and Cervical Cancer
Author Information
Author(s): Wani K M Y, Huilgol N G, Hongyo T, Shah H, Chatterjee N, Nair C K K, Nomura T
Primary Institution: Department of Radiation Biology and Medical Genetics, Graduate School of Medicine, Osaka University
Hypothesis
The bak gene may act as a tumor suppressor gene in cervical carcinoma.
Conclusion
Mutations in the bak gene are more frequent in advanced-stage cervical tumors and are associated with a decreased response to radiotherapy.
Supporting Evidence
- Six mutations were found in the bak gene in 42 cervical cancer specimens.
- Mutations in the bak gene occurred more frequently in advanced-stage tumors.
- Cervical cancer tissues with bak mutations showed a decreased response to radiotherapy.
Takeaway
This study looked at a gene called bak in cervical cancer and found that changes in this gene can make the cancer harder to treat with radiation.
Methodology
Biopsied specimens from cervical cancer patients were analyzed for mutations in the bak gene using PCR and sequencing.
Limitations
The study had a small sample size, which may limit the statistical significance of the findings.
Participant Demographics
Patients had an average age of 51.6 years, with 12 stage II and 30 stage III cases.
Statistical Information
P-Value
P=0.12
Confidence Interval
51.6±3.9 years
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website